Literature DB >> 25034567

Development and validation of the RAND Asthma Control Measure.

Marielena Lara1, Maria Orlando Edelen2, Nicole K Eberhart2, Brian D Stucky2, Cathy D Sherbourne2.   

Abstract

Patient-based measures for asthma control are important in assessing the worldwide impact of this highly prevalent chronic illness. We sought to refine an asthma symptom scale that RAND had previously developed to shorten it and validate it further, as well as reflect updated international expert definitions of asthma control. We conducted rigorous psychometric testing of new and adapted self-administered survey items in a sample of 2032 adults with asthma. The reliability and preliminary validity of the resulting measure, henceforth referred to as the RAND Asthma Control Measure (RAND-ACM), matched or exceeded that of the original RAND measure and others in the literature. RAND-ACM scores for worse asthma control were significantly associated with worse asthma-related quality of life, increased asthma-related healthcare use, Hispanic ethnicity and lower educational level. Evidence for internal consistency was strong with a Cronbach's α of 0.84. We also found adequate concordance between the RAND-ACM and the Global Initiative for Asthma categories of "uncontrolled", "partly controlled" and "controlled" asthma. The RAND-ACM, a five-item self-reported asthma control survey measure, performs well in a large ethnically-diverse sample of US adults with asthma and provides a cost-free alternative to other asthma control measures currently available. ©ERS 2014.

Entities:  

Mesh:

Year:  2014        PMID: 25034567      PMCID: PMC4291171          DOI: 10.1183/09031936.00051614

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  15 in total

1.  A scale for the measurement of quality of life in adults with asthma.

Authors:  G B Marks; S M Dunn; A J Woolcock
Journal:  J Clin Epidemiol       Date:  1992-05       Impact factor: 6.437

2.  An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice.

Authors:  Helen K Reddel; D Robin Taylor; Eric D Bateman; Louis-Philippe Boulet; Homer A Boushey; William W Busse; Thomas B Casale; Pascal Chanez; Paul L Enright; Peter G Gibson; Johan C de Jongste; Huib A M Kerstjens; Stephen C Lazarus; Mark L Levy; Paul M O'Byrne; Martyn R Partridge; Ian D Pavord; Malcolm R Sears; Peter J Sterk; Stuart W Stoloff; Sean D Sullivan; Stanley J Szefler; Mike D Thomas; Sally E Wenzel
Journal:  Am J Respir Crit Care Med       Date:  2009-07-01       Impact factor: 21.405

3.  Comparing Global Initiative for Asthma (GINA) criteria with the Childhood Asthma Control Test (C-ACT) and Asthma Control Test (ACT).

Authors:  B B Koolen; M W H Pijnenburg; H J L Brackel; A M Landstra; N J van den Berg; P J F M Merkus; W C J Hop; A A P H Vaessen-Verberne
Journal:  Eur Respir J       Date:  2011-03-15       Impact factor: 16.671

4.  An evaluation of an asthma quality of life questionnaire as a measure of change in adults with asthma.

Authors:  G B Marks; S M Dunn; A J Woolcock
Journal:  J Clin Epidemiol       Date:  1993-10       Impact factor: 6.437

5.  Asthma prevalence, health care use, and mortality: United States, 2005-2009.

Authors:  Lara J Akinbami; Jeanne E Moorman; Xiang Liu
Journal:  Natl Health Stat Report       Date:  2011-01-12

6.  An English and Spanish Pediatric Asthma Symptom Scale.

Authors:  M Lara; C Sherbourne; N Duan; L Morales; P Gergen; R H Brook
Journal:  Med Care       Date:  2000-03       Impact factor: 2.983

7.  Quantifying asthma symptoms in adults: the Lara Asthma Symptom Scale.

Authors:  Pamela Runge Wood; Brad Smith; Louise O'Donnell; Autumn Dawn Galbreath; Marielena Lara; Emma Forkner; Jay I Peters
Journal:  J Allergy Clin Immunol       Date:  2007-11-05       Impact factor: 10.793

8.  Reliability and validity of a chinese version of the pediatric asthma symptoms scale.

Authors:  Chia-Ying Chen; Li-Hua Lo
Journal:  J Nurs Res       Date:  2007-06       Impact factor: 1.682

9.  Asthma Control Test: reliability, validity, and responsiveness in patients not previously followed by asthma specialists.

Authors:  Michael Schatz; Christine A Sorkness; James T Li; Philip Marcus; John J Murray; Robert A Nathan; Mark Kosinski; Trudy B Pendergraft; Priti Jhingran
Journal:  J Allergy Clin Immunol       Date:  2006-03       Impact factor: 10.793

10.  A new perspective on concepts of asthma severity and control.

Authors:  D R Taylor; E D Bateman; L-P Boulet; H A Boushey; W W Busse; T B Casale; P Chanez; P L Enright; P G Gibson; J C de Jongste; H A M Kerstjens; S C Lazarus; M L Levy; P M O'Byrne; M R Partridge; I D Pavord; M R Sears; P J Sterk; S W Stoloff; S J Szefler; S D Sullivan; M D Thomas; S E Wenzel; H K Reddel
Journal:  Eur Respir J       Date:  2008-09       Impact factor: 16.671

View more
  4 in total

1.  A Clinically Integrated mHealth App and Practice Model for Collecting Patient-Reported Outcomes between Visits for Asthma Patients: Implementation and Feasibility.

Authors:  Robert S Rudin; Christopher H Fanta; Nabeel Qureshi; Erin Duffy; Maria O Edelen; Anuj K Dalal; David W Bates
Journal:  Appl Clin Inform       Date:  2019-10-16       Impact factor: 2.342

2.  Validation of Asthma Control Assessment Among Urban Adolescents Using the Asthma Control and Communication Instrument.

Authors:  Sande O Okelo; Andrew L Bilderback; Maria Fagnano; Jill S Halterman
Journal:  J Allergy Clin Immunol Pract       Date:  2018-10-11

3.  Understanding asthma-specific quality of life: moving beyond asthma symptoms and severity.

Authors:  Brian D Stucky; Cathy D Sherbourne; Maria Orlando Edelen; Nicole K Eberhart
Journal:  Eur Respir J       Date:  2015-04-16       Impact factor: 16.671

4.  Core Components for a Clinically Integrated mHealth App for Asthma Symptom Monitoring.

Authors:  Robert S Rudin; Christopher H Fanta; Zachary Predmore; Kevin Kron; Maria O Edelen; Adam B Landman; Eyal Zimlichman; David W Bates
Journal:  Appl Clin Inform       Date:  2017-12-14       Impact factor: 2.342

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.